ISRCTN87375595已完成2 期
A phase II study of vinblastine, endoxana (cyclophosphamide), procarbazine, prednisolone, etoposide, mitoxantrone and bleomycin in patients with Hodgkin's lymphoma aged over 60 years
ewcastle Hospitals NHS Trust (UK)0 个研究点目标入组 150 人开始时间: 2006年8月18日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
2012 results in https://www.ncbi.nlm.nih.gov/pubmed/22577177
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Histologically confirmed classical Hodgkin's Lymphoma (HL)
- •2. No previous treatment for HL
- •3. Aged over 60
- •4. Non fragile patients, i.e. patient?s mental and physical status must be sufficient to withstand the treatment described
- •5. No concomitant neoplasia or known Human Immunodeficiency Virus (HIV) infection
- •6. Written informed consent
排除标准
- •1. Nodular Lymphocyte Predominance Hodgkin's Lymphoma (NLPHL)
- •2. Aged under 60
- •3. Patient previously treated for HL
- •4. Known HIV infection or concomitant neoplasia
- •5. Fragile patient or significant abnormality of another system (pulmonary, cardiac, renal, and hepatic) which is a contraindication to full dose chemotherapy
- •6. Unable to give informed consent
研究者
相似试验
招募中
2 期
Zanubrutinib and Venetoclax in CLL (ZANU-VEN)Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)NCT05168930Dana-Farber Cancer Institute45
撤回
2 期
Phase 2 Study of Fulvestrant With and Without Entinostat in Postmenopausal Women With ER+ Advanced Breast CancerBreast CancerNCT02115594Syndax Pharmaceuticals
进行中（未招募）
2 期
The Combination of Venetoclax and Obinutuzumab in People With Chronic Lymphocytic Leukemia (CLL)Chronic Lymphocytic Leukemia (CLL)NCT04447768Memorial Sloan Kettering Cancer Center100
已完成
1 期
MUK sixHaematological OncologyDisease: MyelomaCancerMultiple myelomaISRCTN59395590niversity of Leeds (UK)54
进行中（未招募）
2 期
Venetoclax + Azacitidine vs. Induction Chemotherapy in AMLAcute Myeloid LeukemiaNCT04801797Massachusetts General Hospital172